WO2023237480 - STABLE PHARMACEUTICAL COMPOSITIONS COMPRISING 5,10-METHYLENE-(6R)-TETRAHYDROFOLIC ACID AND NACL
National phase entry:
Publication Number
WO/2023/237480
Publication Date
14.12.2023
International Application No.
PCT/EP2023/064968
International Filing Date
05.06.2023
Title **
[English]
STABLE PHARMACEUTICAL COMPOSITIONS COMPRISING 5,10-METHYLENE-(6R)-TETRAHYDROFOLIC ACID AND NACL
[French]
COMPOSITIONS PHARMACEUTIQUES STABLES COMPRENANT DE L'ACIDE 5,10-MÉTHYLÈNE-(6R)-TÉTRAHYDROFOLIQUE ET DU NACL
Applicants **
MERCK PATENT GMBH
Inventors
MOSER, Rudolf
GROEHN, Viola
AMMANN, Thomas
Priority Data
22177928.3
08.06.2022
EP
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter II
* |
| * | |
| * | |
| * | |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2189 | |
| EPO | Filing, Examination, Granting | 11191 | |
| Japan | Filing, Examination, Granting | 2368 | |
| South Korea | Filing, Examination, Granting | 2379 | |
| USA | Filing, Examination, Granting | 4940 |
Total:
23,067
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
The present invention is directed to solid pharmaceutical compositions comprising 5,10-methylene- (6R)-tetrahydrofolic acid and NaCl, as well as processes for obtaining the same, and the use of such products.[French]
La présente invention concerne des compositions pharmaceutiques solides comprenant de l'acide 5,10-méthylène-(6R)-tétrahydrofolique et du NaCl, ainsi que des procédés d'obtention de celles-ci, et l'utilisation de tels produits.